Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels.
Fusco A, Miele L, D'Uonnolo A, Forgione A, Riccardi L, Cefalo C, Barini A, Bianchi A, Giampietro A, Cimino V, Landolfi R, Grieco A, De Marinis L.
Fusco A, et al. Among authors: landolfi r.
Clin Endocrinol (Oxf). 2012 Oct;77(4):531-6. doi: 10.1111/j.1365-2265.2011.04291.x.
Clin Endocrinol (Oxf). 2012.
PMID: 22077984